Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation--focus on the elderly

Gregory Y H Lip1, Deirdre A Lane

  • 1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, UK. g.y.h.lip@bham.ac.uk

Insights

Elderly patients with atrial fibrillation (AF) benefit from oral anticoagulants (OACs) for stroke prevention, showing a positive benefit-risk balance despite increased bleeding risks. Treatment decisions should consider individual patient factors.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Atrial fibrillation (AF) significantly increases stroke risk, particularly in aging populations.
  • Oral anticoagulants (OACs) are effective stroke preventatives but are underutilized in elderly patients due to bleeding concerns.

Purpose of the Study:

  • To evaluate the efficacy and safety of OACs in elderly patients with AF.
  • To compare treatment effects in elderly versus younger patients.
  • To determine the net clinical benefit of OACs for elderly individuals.

Main Methods:

  • Systematic review and evaluation of clinical study data.
  • Analysis of efficacy (stroke/systemic embolism) and safety (bleeding events) of OACs.
  • Comparison of vitamin K antagonists and newer OACs in different age groups.

Main Results:

  • Elderly patients face higher risks for both thromboembolic and bleeding events.
  • OACs demonstrated significant efficacy in stroke prevention, with comparable bleeding risks to controls in most studies.
  • Newer OACs (apixaban, rivaroxaban) showed no age-related interaction in treatment effects versus warfarin; dabigatran showed increased extracranial bleeding in older patients.

Conclusions:

  • Oral anticoagulant therapy offers a favorable benefit-risk profile for elderly patients with atrial fibrillation.
  • OACs are effective in reducing stroke risk in the elderly.
  • Individualized treatment decisions for stroke prevention in AF should balance potential benefits, risks, and patient preferences.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...